These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Functional dyspepsia and irritable bowel syndrome in patients with achalasia and its association with non-cardiac chest pain and a decreased health-related quality of life. Frankhuisen R, Van Herwaarden MA, Heijkoop R, Baron A, Vermeijden R, Smout AJ, Gooszen HG, Samsom M. Scand J Gastroenterol; 2009 Nov; 44(6):687-91. PubMed ID: 19263270 [Abstract] [Full Text] [Related]
6. Dyspepsia and IBS symptoms in patients with NERD, ERD and Barrett's esophagus. Neumann H, Monkemuller K, Kandulski A, Malfertheiner P. Dig Dis; 2008 Nov; 26(3):243-7. PubMed ID: 18463443 [Abstract] [Full Text] [Related]
9. Different segmental transit times in patients with irritable bowel syndrome and "normal" colonic transit time: is there a correlation with symptoms? Bouchoucha M, Devroede G, Dorval E, Faye A, Arhan P, Arsac M. Tech Coloproctol; 2006 Dec; 10(4):287-96. PubMed ID: 17115321 [Abstract] [Full Text] [Related]
10. Gender-related differences in visceral perception in health and irritable bowel syndrome. Kim HS, Rhee PL, Park J, Lee JH, Kim YH, Kim JJ, Rhee JC. J Gastroenterol Hepatol; 2006 Feb; 21(2):468-73. PubMed ID: 16509877 [Abstract] [Full Text] [Related]
11. Prevalence, characteristics, and impact of bloating symptoms in patients with irritable bowel syndrome. Ringel Y, Williams RE, Kalilani L, Cook SF. Clin Gastroenterol Hepatol; 2009 Jan; 7(1):68-72; quiz 3. PubMed ID: 19124113 [Abstract] [Full Text] [Related]
13. Irritable bowel syndrome: a population based study. Khoshkrood-Mansoori B, Pourhoseingholi MA, Safaee A, Moghimi-Dehkordi B, Sedigh-Tonekaboni B, Pourhoseingholi A, Habibi M, Zali MR. J Gastrointestin Liver Dis; 2009 Dec; 18(4):413-8. PubMed ID: 20076812 [Abstract] [Full Text] [Related]
14. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials. Rahimi R, Nikfar S, Abdollahi M. Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935 [Abstract] [Full Text] [Related]
16. Spectra of functional gastrointestinal disorders diagnosed by Rome III integrative questionnaire in a Japanese outpatient office and the impact of overlapping. Nakajima S, Takahashi K, Sato J, Fukuda M, Yamamoto K, Inoue T, Okumura Y, Fujiyama Y. J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S138-43. PubMed ID: 20586856 [Abstract] [Full Text] [Related]
17. Prevalence of irritable bowel syndrome in Korea: population-based survey using the Rome II criteria. Han SH, Lee OY, Bae SC, Lee SH, Chang YK, Yang SY, Yoon BC, Choi HS, Hahm JS, Lee MH, Lee DH, Kim TH. J Gastroenterol Hepatol; 2006 Nov; 21(11):1687-92. PubMed ID: 16984590 [Abstract] [Full Text] [Related]
19. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study. Lee SY, Lee KJ, Kim SJ, Cho SW. Digestion; 2009 Nov; 79(3):196-201. PubMed ID: 19342860 [Abstract] [Full Text] [Related]
20. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population. Hillilä MT, Färkkilä MA. Aliment Pharmacol Ther; 2004 Aug 01; 20(3):339-45. PubMed ID: 15274671 [Abstract] [Full Text] [Related] Page: [Next] [New Search]